Critical Care Devices Market Size

The global critical care devices market size was valued at around USD 60.1 billion in 2024 and is estimated to grow at 5.5% CAGR from 2025 to 2034. Critical care devices are specialized medical equipment used to support and monitor patients in life-threatening situations, typically in intensive care units (ICUs).

These devices are crucial for managing severe health conditions that require continuous monitoring, rapid responses, and advanced medical interventions. Key types include ventilators for respiratory support, infusion pumps for precise medication delivery, patient monitors for vital sign tracking, defibrillators, which was valued at USD 11 billion in 2022, for cardiac emergencies, and dialysis machines for renal failure management.

The increasing prevalence of chronic conditions such as cardiovascular disease, respiratory illnesses, and diabetes is leading to a higher demand for critical care interventions. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. Additionally, acute conditions, including infections and trauma, are driving the need for devices like ventilators, defibrillators, and infusion pumps to manage severe cases.

According to the Centers for Disease Control and Prevention (CDC), over 1.7 million adults in the U.S. develop sepsis each year, and at least 350,000 of these cases result in death. This rising burden of chronic and acute conditions underscores the growing importance of critical care devices in healthcare systems worldwide.

Moreover, the market is likely to be stimulated by an increasing number of product launches, mergers and acquisitions, collaborations, and regional expansions by industry players. For instance, in September 2024, BD, a global leader in medical technology, announced the completion of its acquisition of Edwards Lifesciences' Critical Care product group, renamed as BD Advanced Patient Monitoring. This new division strengthened BD’s portfolio of smart, connected care solutions with advanced monitoring technologies, AI-enabled clinical decision tools, and a robust innovation pipeline. Such initiatives are anticipated to drive significant growth in the market by enhancing innovation, expanding access to advanced monitoring solutions, and increasing competition.